You are here: Industry Insights > COVID-19

News List

INOVIO to Develop dMAb COVID Treatments under DARPA Grant contractpharma
December 16, 2020
$37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.
COVID-19 expedites India’s focus on innovation within pharma: GlobalData expresspharma
December 16, 2020
According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020.
Countries must build consensus around proposal to waive certain IP during COVID-19 pandemic: MSF expresspharma
December 16, 2020
All COVID-19 health tools and technologies should be true global public goods, free from the barriers that patents and other intellectual property impose, it states.
Cipla launches rapid antigen detection test to diagnose COVID-19 expresspharma
December 16, 2020
Cipla announced its partnership with the Premier Medical Corporation for commercialisation of the rapid antigen test kits for COVID-19 in India. The company will commence supply from this week.
eTrueNorth Recruiting COVID-Positive Individuals for ACTIV-2 Clinical Trial prnewswire
December 15, 2020
eTrueNorth, the U.S.-based healthcare technology company that enables laboratory testing at retail pharmacies and enables all surge drive-through COVID-19 specimen collection sites, will begin proactively communicating with COVID-19 positive ...
BASE10, DNA Link Partners on Research to Support Authorization of Antibody Test americanpharmaceuticalreview
December 15, 2020
BASE10 Genetics, DNA Link announced their collaboration on a research project to evaluate the usability of DNA Link's AccuFind COVID-19 IgG antibody test in a healthcare setting.
Ruxolitinib (Jakafi) does not prevent complications due to COVID-19 associated cytokine storm: Study expresspharma
December 15, 2020
Incyte announced that the Phase 3 RUXCOVID study evaluating the safety and efficacy of ruxolitinib (Jakafi), a JAK1/JAK2 inhibitor, plus standard-of-care (SoC) as a treatment for patients 12 years and older with COVID-19 associated cytokine storm did ...
Himalaya study finds herbal immunomodulators effective as adjuvant treatment for COVID-19 expresspharma
December 15, 2020
The study states that adjuvant therapy with Septilin and Bresol along with SOC supports immunity and controls inflammation in COVID-19–positive patients and helps in the recovery of symptoms of post-COVID-19 illness.
US begins COVID-19 vaccinations expresspharma
December 15, 2020
The first US coronavirus immunisations outside of clinical trials were part of a broad campaign by public health authorities and political leaders to reassure Americans of the vaccine’s safety.
Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine prnewswire
December 14, 2020
Eli Lilly and Company and Incyte announced that The New England Journal of Medicine has published peer-reviewed results from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) ...